Tomorrow, May 29, 2021, Chronicle Companies, in collaboration with Mallinckrodt Pharmaceuticals and Scleroderma Canada, is presenting the first Canadian Scleroderma Summit.
The meeting will run from 11:00 a.m. until 1:00 p.m., EDT.
Attendees will be provided with a state-of-therapy overview of this disease, which affects 40,000 Canadians.
Dr. Robert Gniadecki
Dr. Janet Elizabeth Pope
And other experts
Registration is free, and still open. To register, click here.